Mastering the Art of Heart Failure Management - Live
Duration: 6 hours
Recommended for: GPs
An estimated 480,000 Australians live with chronic heart failure (CHF) – a condition with a mortality rate comparable to the most common forms of cancer. Optimal management of ambulatory CHF patients in the general practice setting has been shown to reduce the rate of hospitalisation and death, and the role of general practice team in managing this burdensome disease will become even more central as the population ages.
This 6-module interactive ALM will bring GPs and practice nurses fully up to date with the latest evidence-based recommendations for the diagnosis and management of CHF, focussing on the appropriate use of medications that have been demonstrated, when used optimally, to significantly reduce the risk of hospitalisation and death. Evidence-based guidance for the use of sacubitril/valsartan is included - the first in class of angiotensin receptor neprilysin inhibitors (ARNIs), with proven superior efficacy to ACE inhibitors. Essential concepts in non-pharmacologic management of CHF and pointers to GP-centred multi-disciplinary management of CHF are also featured. This ALM will bring clarity to a complex area of clinical practice, helping GPs to provide optimal care with confidence to an important and growing patient group.
- Understand the aetiology, risk factors, signs and symptoms of chronic heart failure (CHF)
- Know how to investigate CHF in order to determine an accurate diagnosis and prognosis for optimal management
- Be familiar with current evidence-based recommendations for the pharmacologic treatment of CHF, in particular the importance of optimising drug treatment to minimise risk of hospitalisation and death
- Understand the importance of non-pharmacological approaches to CHF management, particularly nurse-led patient education to encourage self-management
- Understand how general-practice led models of care that focus on co-ordination of AHP and specialist services may improve outcomes for CHF patients
This ALM is accredited by the RACGP, and attendees will receive 40 Category 1 points upon completion.